Literature DB >> 25126236

Where generics and biologics meet.

Melisa J Heinrichs1, Gary M Owens2.   

Abstract

Year:  2008        PMID： 25126236      PMCID： PMC4115300     

Source DB:  PubMed          Journal:  Am Health Drug Benefits        ISSN： 1942-2962


× No keyword cloud information.
  4 in total

Review 1.  Biosimilar drugs : concerns and opportunities.

Authors:  Armando A Genazzani; Giovanni Biggio; Achille Patrizio Caputi; Mario Del Tacca; Filippo Drago; Roberto Fantozzi; Pier Luigi Canonico
Journal:  BioDrugs       Date:  2007       Impact factor: 5.807

Review 2.  The challenge of biosimilars.

Authors:  H Mellstedt; D Niederwieser; H Ludwig
Journal:  Ann Oncol       Date:  2007-09-14       Impact factor: 32.976

3.  Where the wall will fall first.

Authors:  John Carroll
Journal:  Biotechnol Healthc       Date:  2007-08

Review 4.  Biosimilars: recent developments.

Authors:  A Covic; M K Kuhlmann
Journal:  Int Urol Nephrol       Date:  2007-02-27       Impact factor: 2.370
  4 in total
  2 in total

1.  Presidential candidates strong supporters of greater access to generics and biosimilars.

Authors:  Dalia Buffery
Journal:  Am Health Drug Benefits       Date:  2008-10

Review 2.  The Breakthrough of Biosimilars: A Twist in the Narrative of Biological Therapy.

Authors:  Eva Rahman Kabir; Shannon Sherwin Moreino; Mohammad Kawsar Sharif Siam
Journal:  Biomolecules       Date:  2019-08-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.